NYSEMKT: OGEN
Oragenics Inc Stock Ownership - Who owns Oragenics?

Insider buying vs selling

Have Oragenics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Odyssey Health Inc10% Owner2025-06-185,044$4.26
$21.49kSell
Odyssey Health Inc10% Owner2025-06-172,000$4.46
$8.92kSell
Odyssey Health Inc10% Owner2025-06-165,000$4.45
$22.25kSell
Odyssey Health Inc10% Owner2025-06-135,000$4.27
$21.35kSell
Alan W. DuntonDirector2024-12-0666$0.36
$23.76Sell
Fred TellingDirector2024-12-063,597$0.36
$1.29kSell

1 of 1

OGEN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OGEN insiders and whales buy or sell their stock.

OGEN Shareholders

What type of owners hold Oragenics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Randal J. Kirk476.80%19,874,069$22.66MInsider
Koski Family LP235.92%9,833,595$11.21MInsider
Jeffrey D. Hillman78.70%3,280,434$3.74MInsider
Christine L. Koski50.38%2,100,000$2.39MInsider
David Brian Hirsch23.99%1,000,000$1.14MInsider
Robert T. Zahradnik21.14%881,000$1.00MInsider
George T. Hawes17.88%745,397$849.75kInsider
Mento Soponis12.48%520,133$592.95kInsider
John N. Bonfiglio9.24%385,255$439.19kInsider
Bruce A. Cassidy Sr.8.51%354,728$404.39kInsider

1 of 3

OGEN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OGEN0.00%100.00%Net Selling
QLGN0.01%99.99%
INM0.38%24.13%
PLRZ0.00%0.00%
CANF0.00%0.00%

Oragenics Stock Ownership FAQ

Who owns Oragenics?

Oragenics (NYSEMKT: OGEN) is owned by 0.02% institutional shareholders, 951.18% Oragenics insiders, and 0.00% retail investors. Randal J. Kirk is the largest individual Oragenics shareholder, owning 19.87M shares representing 476.80% of the company. Randal J. Kirk's Oragenics shares are currently valued at $22.26M.

If you're new to stock investing, here's how to buy Oragenics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.